Abstract
The effects of luminal instillation of 16,16 dimethyl PGE2 (dmPGE2) on gastric acid secretion and back diffusion of H+ were studied in anaesthetised dogs which were prepared with a segment of the greater curvature of the stomach mounted in a double lumen chamber. This model permitted simultaneous evaluation of two segments of mucosa, one control and the other test, supplied by the same vascular pedicle. Imfusion of histamine (1.0 microgram/kg/min, intravenously) stimulated brisk acid secretion in both chambers. Topical application of 25 microgram dmPGE2 in 20 ml 0.3 M HC1 to the test chamber for 30 minutes prevented acid secretion from the test mucosa during a second histamine infusion. Since the control chamber showed no evidence of inhibition this indicates that dmPGE2 acted directly on the secretory cells, rather than after absorption from the bloodstream. This observation, however, does not exclude a possible local effect on mucosal blood flow. Direct exposure of the gastric mucosa to dmPGE2 increased the rate of back diffusion of H+ because of disruption of the permeability barrier, indicated by increased H+ back diffusion, Na+ efflux, and a reduction in potential difference. However, H+ loss was small compared to the reduction in acid output.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- MOODY F. G., DURBIN R. P. EFFECTS OF GLYCINE AND OTHER INSTILLATES ON CONCENTRATION OF GASTRIC ACID. Am J Physiol. 1965 Jul;209:122–126. doi: 10.1152/ajplegacy.1965.209.1.122. [DOI] [PubMed] [Google Scholar]
- Mihas A. A., Gibson R. G., Hirschowitz B. I. Inhibition of gastric secretion in the dog by 16,16-dimethyl prostaglandin E2. Am J Physiol. 1976 Feb;230(2):351–356. doi: 10.1152/ajplegacy.1976.230.2.351. [DOI] [PubMed] [Google Scholar]
- Nylander B., Robert A., Andersson S. Gastric secretory inhibition by certain methyl analogs of prostaglandin E2 following intestinal administration in man. Scand J Gastroenterol. 1974 Nov;9(8):759–762. [PubMed] [Google Scholar]
- O'Brien P. E., Carter D. C. Effect of gastric secretory inhibitors on the gastric mucosal barrier. Gut. 1975 Jun;16(6):437–442. doi: 10.1136/gut.16.6.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robert A., Mylander B., Andersson S. Marked inhibition of gastric secretion by two prostaglandin analogs given orally to man. Life Sci. 1974 Feb 1;14(3):533–538. doi: 10.1016/0024-3205(74)90367-1. [DOI] [PubMed] [Google Scholar]
- Robert A., Schultz J. R., Nezamis J. E., Lancaster C. Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration. Gastroenterology. 1976 Mar;70(3):359–370. [PubMed] [Google Scholar]
- Silen W. Founder's lecture: New concepts of the gastric mucosal barrier. Am J Surg. 1977 Jan;133(1):8–12. doi: 10.1016/0002-9610(77)90184-2. [DOI] [PubMed] [Google Scholar]
- Wilson D. E., Winnan G., Quertermus J., Tao P. Effects of an orally administered prostaglandin analogue (16, 16-dimethyl prostaglandin E2) on human gastric secretion. Gastroenterology. 1975 Sep;69(3):607–611. [PubMed] [Google Scholar]